Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Up 36% Nice. Bigger move coming this week ?
LeBron James, Kobe Byrant, Ronaldinho
$IBGR / DRYWORLD and Ronaldinho @10Ronaldinho
— PENNIES to STACKS (@PENNIEStoSTACKS) October 18, 2022
with 21,000,000 followers
I wonder how many of Ronaldinho followers will buy these productshttps://t.co/CzpTmq6Rk1
I always wondered who this guy with @KingJames and @kobebryant was when I saw this picture years ago, now I know pic.twitter.com/Zi8G7N1GjI
(((((( ALERT )))))) - $IBGR - HUGE HOLIDAY PLAY. IMO
#SOCCER $WMT $M $KSS $JWN $TGT $GPS $COST
https://www.dryworldshop.com
https://www.dryworldshop.com/a/pf_preview?id=d0929dc6-2c8e-4ff0-8e80-7551a80d74e1
https://finance.yahoo.com/news/ronaldinho-dryworld-global-collection-drops-225900433.html
No disrespect but AAPL is a Trillion $ company and has a massive cash reserve.
How much cash reserves does ABQQ have ?
"Approval of an amendment to the Company’s Articles of Incorporation (the “Amendment”) to increase the total number of authorized shares of our Common Stock from one billion (1,000,000,000) shares to ten billion (10,000,000,000) shares."
https://www.otcmarkets.com/filing/html?id=16090584&guid=W2R-kK05Od9kdth
WOW REALLY ? ALL SOME THAT KNEW HAD TO DO WAS POST THE LINK
Thank you! Will be filed a 10-K on time.
— ABQQ (@ABIntlGroup) October 12, 2022
TNSP now HMBL went to Dollars with 4 BILLION or so in the OS
https://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=hmbl&insttype=&freq=1&show=&time=9
ABQQ OS 427,594,207 10/10/2022
https://www.otcmarkets.com/stock/ABQQ/security
ABQQ More positive news expected, stay tuned
$ABQQ announced efforts to go back trade on QB ASAP. The company is immediately stops issuance any convertible debt or preferred stock.Will be arranged repayments of all note/debts and preferred stock that the company previously issued. Will keep investors posted update progress.
— ABQQ (@ABIntlGroup) October 12, 2022
is expected to generate a new and profitable revenue stream immediately following its launch derived from its hybrid subscription and advertising business model.
ABQQ OS 427,594,207 10/10/2022
https://www.otcmarkets.com/stock/ABQQ/security
.0017
https://www.the-numbers.com/market now that I watched this movie I see that the Movie on the wall isn't this Movie
Will be filed the annual report on time. Thank you
— ABQQ (@ABIntlGroup) October 12, 2022
🚨 $ABQQ In .0015 ✔️
— NarutOTC (@NarutOTC_) October 12, 2022
✅ Working to go back trade on QB status ( They need to trade for a minimum of 30 days in .01 )
✅ STOP issuing convertible debts
✅ Paying all debts/notes left!
✅ 315M float
✅ $2M Revenues, $6M Assets
✅ WAY oversold! https://t.co/sRA4WFOQ7d
Do you know how many theaters ABQQ has at the below building and do you know if this will be the first or one of the first movies it will show ?
$ABQQ #MGM studios https://t.co/7JAY8E2LoL
— ABQQ (@ABIntlGroup) October 11, 2022
🚨 $ABQQ In .0015 ✔️
— NarutOTC (@NarutOTC_) October 12, 2022
✅ Working to go back trade on QB status ( They need to trade for a minimum of 30 days in .01 )
✅ STOP issuing convertible debts
✅ Paying all debts/notes left!
✅ 315M float
✅ $2M Revenues, $6M Assets
✅ WAY oversold! https://t.co/sRA4WFOQ7d
🚨 $ABQQ In .0015 ✔️
— NarutOTC (@NarutOTC_) October 12, 2022
✅ Working to go back trade on QB status ( They need to trade for a minimum of 30 days in .01 )
✅ STOP issuing convertible debts
✅ Paying all debts/notes left!
✅ 315M float
✅ $2M Revenues, $6M Assets
✅ WAY oversold! https://t.co/sRA4WFOQ7d
Watching Thanks
More NEWS soon according to todays Tweet
https://twitter.com/PENNIEStoSTACKS/status/1580203972434231297
I say the same for this one https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170177219
What happened to the last drill ?
I haven't been following
OIL FINALLY THIS WINTER ?
10 X's + Before XMAS >>>> ? >>>> https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170177219
Thanks and ABQQ NY Theater opening soon, could be on time for Holiday Movie releases . https://finance.yahoo.com/news/ab-intl-group-announces-obtain-120000344.html
With OS updated 10/10/2022
https://www.otcmarkets.com/stock/ABQQ/security
Then this today with much more to come
$ABQQ announced efforts to go back trade on QB ASAP. The company is immediately stops issuance any convertible debt or preferred stock.Will be arranged repayments of all note/debts and preferred stock that the company previously issued. Will keep investors posted update progress.
— ABQQ (@ABIntlGroup) October 12, 2022
You're welcome and stay tuned for much more
ABQQ NY Theater opening soon, could be on time for Holiday Movie releases . https://finance.yahoo.com/news/ab-intl-group-announces-obtain-120000344.html
With OS updated 10/10/2022
https://www.otcmarkets.com/stock/ABQQ/security
Then this today with much more to come
$ABQQ announced efforts to go back trade on QB ASAP. The company is immediately stops issuance any convertible debt or preferred stock.Will be arranged repayments of all note/debts and preferred stock that the company previously issued. Will keep investors posted update progress.
— ABQQ (@ABIntlGroup) October 12, 2022
Good Morning and a Good ABQQ Tweet for you
$ABQQ announced efforts to go back trade on QB ASAP. The company is immediately stops issuance any convertible debt or preferred stock.Will be arranged repayments of all note/debts and preferred stock that the company previously issued. Will keep investors posted update progress.
— ABQQ (@ABIntlGroup) October 12, 2022
ABQQ - " immediately stops issuance any convertible debt or preferred stock. Will be arranged repayments of all note/debts and preferred stock that the company previously issued. Will keep investors posted update progress."
$ABQQ announced efforts to go back trade on QB ASAP. The company is immediately stops issuance any convertible debt or preferred stock.Will be arranged repayments of all note/debts and preferred stock that the company previously issued. Will keep investors posted update progress.
— ABQQ (@ABIntlGroup) October 12, 2022
ABQQ - "announced efforts to go back trade on QB ASAP. The company is immediately stops issuance any convertible debt or preferred stock.Will be arranged repayments of all note/debts and preferred stock that the company previously issued. Will keep investors posted update progress."
$ABQQ announced efforts to go back trade on QB ASAP. The company is immediately stops issuance any convertible debt or preferred stock.Will be arranged repayments of all note/debts and preferred stock that the company previously issued. Will keep investors posted update progress.
— ABQQ (@ABIntlGroup) October 12, 2022
ABQQ - "announced efforts to go back trade on QB ASAP. The company is immediately stops issuance any convertible debt or preferred stock.Will be arranged repayments of all note/debts and preferred stock that the company previously issued. Will keep investors posted update progress."
$ABQQ announced efforts to go back trade on QB ASAP. The company is immediately stops issuance any convertible debt or preferred stock.Will be arranged repayments of all note/debts and preferred stock that the company previously issued. Will keep investors posted update progress.
— ABQQ (@ABIntlGroup) October 12, 2022
ABQQ "announced efforts to go back trade on QB ASAP. The company is immediately stops issuance any convertible debt or preferred stock.Will be arranged repayments of all note/debts and preferred stock that the company previously issued. Will keep investors posted update progress."
$ABQQ announced efforts to go back trade on QB ASAP. The company is immediately stops issuance any convertible debt or preferred stock.Will be arranged repayments of all note/debts and preferred stock that the company previously issued. Will keep investors posted update progress.
— ABQQ (@ABIntlGroup) October 12, 2022
OS ONLY 427,594,207 - 10/10/2022
https://www.otcmarkets.com/stock/ABQQ/security
A few more days of 100 Million buying could lock this OS up if folks would hold.
I'm seeing AS of 1 Billion as of a couple of days ago
https://www.otcmarkets.com/stock/ABQQ/security
Where are you seeing 10 ?
Maybe INKW can sell its drink in the NEWLY REMODELED ABQQ SOON to COME NY THEATERS.
https://finance.yahoo.com/news/ab-intl-group-announces-obtain-120000344.html
ABQQ "United Artists Releasing offers content creators an alternative distribution option outside of the studio system, and in addition to supporting Annapurna, MGM and Orion film slates, the company also releases third-party films."
https://finance.yahoo.com/news/ab-intl-group-announces-obtain-120000344.html
COMS OS 96.44M - .0609 as of this writing
https://finance.yahoo.com/quote/COMS/key-statistics?p=COMS
https://stocktwits.com/PENNIESTOSTACKS
https://www.stockscores.com/chart.asp?TickerSymbol=COMS&TimeRange=15&Interval=60&Volume=1&ChartType=CandleStick&Stockscores=None&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=100&Indicator1=Vol&Indicator2=AccDist&Indicator3=SStoch&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen
$7.94 "Consensus Analyst Price Target $150.00"
https://www.marketbeat.com/stocks/NASDAQ/INM/price-target
INM-755 for the treatment of Epidermolysis Bullosa (“EB”)
Enrollment and patient treatment in the Company’s Phase 2 clinical trial, 755-201-EB, continued throughout the fourth quarter and, to date, nine patients been enrolled and completed treatment in the study. The 755-201-EB study is designed to enroll up to 20 patients. InMed is evaluating the safety of INM-755 (cannabinol) cream and its preliminary efficacy in treating symptoms and wound healing over a 28-day treatment period. This study marks the first time cannabinol (“CBN”) has advanced to a Phase 2 clinical trial to be investigated as a therapeutic option to treat a disease.
In the fiscal fourth quarter, based on the safety data of the first five adult patients who completed treatment with INM-755 CBN cream for the treatment of EB in the Phase 2 clinical trial, an independent Data Monitoring Committee (“DMC”) agreed it is safe to allow the enrollment of adolescent patients, defined as persons aged twelve to seventeen. The first adolescent patient with EB has been enrolled into the clinical trial and has completed treatment at the clinical site in Greece during the summer.
Following a period of downtime during the summer months, patient screening and enrollment has now recommenced at sites across Europe. The Company anticipates that the inclusion of adolescents will have a positive impact on the enrollment rate for the remainder of the clinical trial. Enrollment is anticipated to complete during the calendar year 2022.
InMed’s Phase 2 clinical trial now has nine clinical trial sites fully activated to screen and enroll patients. Two more sites are expected to be fully activated soon. The clinical trial is taking place in seven countries including Austria, Germany, Greece, France, Italy, Israel and Spain.
INM-088 for the treatment of glaucoma
In the fourth fiscal quarter, the Company completed a pre-Investigational New Drug (“pIND”) application discussion with the U.S. Food and Drug Administration (“FDA”) regarding manufacturing, preclinical studies and early clinical development plans for INM-088, a CBN formulation in development for glaucoma. The Company gained alignment with FDA on the design of the initial Phase 1-2 clinical trial to gather preliminary data on the safety and efficacy of INM-088 treatment. Management expects to file regulatory applications in the first half of the calendar year 2024 to initiate a human clinical trial.
As referenced in a recent international journal publication [Biochimica et Biophysical Acta (BBA) - Molecular Basis of Disease, Volume 1868, Issue 3, 1 March 2022, 166325], InMed’s preclinical research demonstrates that CBN is effective at providing neuroprotection to the retinal ganglion cells and reducing intraocular pressure in glaucoma models, and outperformed several other naturally occurring cannabinoids, including tetrahydrocannabinol (“THC”).